Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

140 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Residual β-Cell Function Is Associated With Longer Time in Range in Individuals With Type 1 Diabetes.
Fuhri Snethlage CM, McDonald TJ, Oram RD, de Groen P, Rampanelli E, Schimmel AWM, Holleman F, Siegelaar S, Hoekstra J, Brouwer CB, Knop FK, Verchere CB, van Raalte DH, Roep BO, Nieuwdorp M, Hanssen NMJ. Fuhri Snethlage CM, et al. Among authors: holleman f. Diabetes Care. 2024 Jul 1;47(7):1114-1121. doi: 10.2337/dc23-0776. Diabetes Care. 2024. PMID: 37535870 Free PMC article.
A Changed Gut Microbiota Diversity Is Associated With Metabolic Improvements After Duodenal Mucosal Resurfacing With Glucagon-Like-Peptide-1 Receptor Agonist in Type 2 Diabetes in a Pilot Study.
Meiring S, van Baar ACG, Sørensen N, Holleman F, Soeters MR, Nieuwdorp M, Bergman JJGHM. Meiring S, et al. Among authors: holleman f. Front Clin Diabetes Healthc. 2022 Jul 5;3:856661. doi: 10.3389/fcdhc.2022.856661. eCollection 2022. Front Clin Diabetes Healthc. 2022. PMID: 36992788 Free PMC article.
Effects of sitagliptin on counter-regulatory and incretin hormones during acute hypoglycaemia in patients with type 1 diabetes: a randomized double-blind placebo-controlled crossover study.
Schopman JE, Hoekstra JBL, Frier BM, Ackermans MT, de Sonnaville JJJ, Stades AM, Zwertbroek R, Hartmann B, Holst JJ, Knop FK, Holleman F. Schopman JE, et al. Among authors: holleman f. Diabetes Obes Metab. 2015 Jun;17(6):546-553. doi: 10.1111/dom.12453. Epub 2015 Mar 24. Diabetes Obes Metab. 2015. PMID: 25694217 Clinical Trial.
Endothelial glycocalyx damage coincides with microalbuminuria in type 1 diabetes.
Nieuwdorp M, Mooij HL, Kroon J, Atasever B, Spaan JA, Ince C, Holleman F, Diamant M, Heine RJ, Hoekstra JB, Kastelein JJ, Stroes ES, Vink H. Nieuwdorp M, et al. Among authors: holleman f. Diabetes. 2006 Apr;55(4):1127-32. doi: 10.2337/diabetes.55.04.06.db05-1619. Diabetes. 2006. PMID: 16567538
A 24-week, randomized, treat-to-target trial comparing initiation of insulin glargine once-daily with insulin detemir twice-daily in patients with type 2 diabetes inadequately controlled on oral glucose-lowering drugs.
Swinnen SG, Dain MP, Aronson R, Davies M, Gerstein HC, Pfeiffer AF, Snoek FJ, Devries JH, Hoekstra JB, Holleman F. Swinnen SG, et al. Among authors: holleman f. Diabetes Care. 2010 Jun;33(6):1176-8. doi: 10.2337/dc09-2294. Epub 2010 Mar 3. Diabetes Care. 2010. PMID: 20200301 Free PMC article. Clinical Trial.
140 results